Southern Clinical Trials Group
Southern Clinical Trials Group (SCTG) was established in 2011 to provide clinical governance, business development and administrative oversight to the trial sites.
SCTG now has 6 sites, 1 in Christchurch, 4 in Auckland and a further site is currently being established in Nelson. All sites are based in or around primary care and have access to large General Practice databases. All SCT sites have experienced Principal Investigators and Study Coordinators.
SCTG sites have completed a wide range of phase 1B – 4 clinical trials. Recent trials include vaccine studies (influenza, hepatitis B, pneumococcal and HPV), lipid lowering, diabetes, osteoarthritis, immune response, migraine, soft tissue injuries, COPD, atopic dermatitis, asthma, rapid antigen devices, urticaria, aging, gout, endometriosis, cardiovascular outcomes, pain, depression and acute influenza.
SCTG sites are frequently amongst the highest study recruiters in the Asia Pacific region. All SCTG sites use a common CTMS and electronic source documents.
SCTG is proud to be part of the large Australian/New Zealand network Pacific Clinical Research Network.
The head office is at Forte 2, 132 Peterborough St, Christchurch, New Zealand.
For more information: www.sctrials.co.nz